JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06689917
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China, Wuhan, Hubei, China
Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome
- Conditions
- Blau Syndrome
- Interventions
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06688838
- Locations
- 🇨🇳
Yikai YU, Wuhan, Hubei, China
Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease
Active, not recruiting
- Conditions
- Crohn Disease
- Interventions
- Drug: enteral nutritionDrug: ImmunotherapyDrug: biological agentsOther: fecal microbiota transplantationDrug: Glucocorticoids
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06673134
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, 430030, Wuhan,, China
Sevoflurane Versus Propofol in Endovascular Coiling of Cerebral Aneurysm
Completed
- Conditions
- PropofolSevoflurane
- Interventions
- Drug: Anesthesia Agent
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06666959
- Locations
- 🇨🇳
Department of Neurosurgery, Wuhan, Hubei, China
Spinal Anesthesia Using a Needle Through Needle technique-a Retrospective Report of 1862 Cases
Completed
- Conditions
- Spinal Anesthesia
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 1862
- Registration Number
- NCT06656793
- Locations
- 🇨🇳
Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
Recruiting
- Conditions
- Biliary Tract Cancer
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06653127
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
Recruiting
- Conditions
- Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06653062
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy
Not Applicable
Recruiting
- Conditions
- Median Sternotomy
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 38
- Registration Number
- NCT06646172
- Locations
- 🇨🇳
Tianzhu Liu, Wuhan, Hubei, China
Intelligent Segmentation Algorithm of Ultrasonic Image
Recruiting
- Conditions
- Segmentation
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 5000
- Registration Number
- NCT06646679
- Locations
- 🇨🇳
Tianzhu Liu, Wuhan, Hubei, China
The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
Phase 1
Recruiting
- Conditions
- Neuromyelitis Optica Spectrum Disorders
- Interventions
- Drug: Extracellular vesicles derived from human-induced neural stem cells for intrathecal injectionDrug: A placebo of extracellular vesicles derived from human-induced neural stem cells for intrathecal injection
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 69
- Registration Number
- NCT06620809
- Locations
- 🇨🇳
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
© Copyright 2025. All Rights Reserved by MedPath